Skip to main content
Huseyin Naci on Muck Rack

Huseyin Naci

As seen in: Nature, PLOS Medicine, British Journal of Sports Medicine, Evidence-Based Mental Health, The BMJ, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, The Lancet, Value in Health Journal, Health Policy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Huseyin

Contact Huseyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study

|
By Rylee McGonigle, Huseyin Naci, Maximilian Siebert, Michelle Ouvina
| PLOS Medicine Verified
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: McGonigle R, Naci H, Siebert M, Ouvina M, Gutiérrez-Sacristán A, Wagner AK, et al. (2025) Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study. PLoS Med 22(12): e1004651.
Open in Who Shared Issue with article?

Improving productivity in the NHS

|
By Sally Gainsbury, Huseyin Naci, Nuffield Trust
| The BMJ Verified
Sally Gainsbury, senior policy analyst1, Huseyin Naci, associate professor of health policy2 1Nuffield Trust, London, UK 2Department of Health Policy, London School of Economics and Political Science, London, UK Correspondence to: S Gainsbury Sally.gainsbury{at}nuffieldtrust.org.uk Innovation may fall short of delivering improvement The UK government’s 10 year health plan for England1 was published against concerns of ailing productivity within the NHS2 and the wider UK economy.3 It was...
Open in Who Shared Issue with article?

Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis - The Lancet

|
By Huseyin Naci, Peter Murphy, Beth Woods
| The Lancet Verified
Introduction Few decisions in health care lead to as much controversy as those concerning the funding, or lack thereof, of new drugs.
Open in Who Shared Issue with article?
See all 46 licensed articles (49 Total)